Cullen Frost Bankers Inc. Cuts Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Cullen Frost Bankers Inc. decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 52,994 shares of the medical equipment provider’s stock after selling 149 shares during the quarter. Cullen Frost Bankers Inc.’s holdings in Intuitive Surgical were worth $17,878,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA grew its position in shares of Intuitive Surgical by 0.3% during the fourth quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 8,899 shares of the medical equipment provider’s stock worth $3,002,000 after acquiring an additional 27 shares during the last quarter. Liberty Capital Management Inc. raised its stake in Intuitive Surgical by 3.8% in the 4th quarter. Liberty Capital Management Inc. now owns 815 shares of the medical equipment provider’s stock valued at $275,000 after purchasing an additional 30 shares during the last quarter. Miracle Mile Advisors LLC raised its stake in Intuitive Surgical by 2.3% in the 4th quarter. Miracle Mile Advisors LLC now owns 1,438 shares of the medical equipment provider’s stock valued at $485,000 after purchasing an additional 32 shares during the last quarter. Ausdal Financial Partners Inc. raised its stake in Intuitive Surgical by 1.5% in the 4th quarter. Ausdal Financial Partners Inc. now owns 2,192 shares of the medical equipment provider’s stock valued at $739,000 after purchasing an additional 33 shares during the last quarter. Finally, Venturi Wealth Management LLC raised its stake in Intuitive Surgical by 10.7% in the 4th quarter. Venturi Wealth Management LLC now owns 341 shares of the medical equipment provider’s stock valued at $115,000 after purchasing an additional 33 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently commented on the stock. Royal Bank of Canada upped their price objective on shares of Intuitive Surgical from $400.00 to $432.00 and gave the company an “outperform” rating in a research note on Wednesday, January 24th. Wells Fargo & Company boosted their target price on Intuitive Surgical from $363.00 to $416.00 and gave the stock an “overweight” rating in a report on Friday, January 19th. Stifel Nicolaus upped their price target on Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, April 8th. Jefferies Financial Group upped their target price on Intuitive Surgical from $365.00 to $375.00 and gave the company a “hold” rating in a research report on Friday, April 19th. Finally, BTIG Research raised their target price on Intuitive Surgical from $412.00 to $421.00 and gave the company a “buy” rating in a research note on Friday, April 19th. Five equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $396.17.

Insider Transactions at Intuitive Surgical

In other news, EVP Robert Desantis sold 1,498 shares of the business’s stock in a transaction that occurred on Friday, April 26th. The stock was sold at an average price of $369.92, for a total value of $554,140.16. Following the transaction, the executive vice president now owns 5,507 shares in the company, valued at approximately $2,037,149.44. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In related news, EVP Robert Desantis sold 1,498 shares of the company’s stock in a transaction that occurred on Friday, April 26th. The stock was sold at an average price of $369.92, for a total value of $554,140.16. Following the transaction, the executive vice president now owns 5,507 shares in the company, valued at $2,037,149.44. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP Marshall Mohr sold 108,790 shares of the stock in a transaction on Wednesday, February 28th. The stock was sold at an average price of $385.08, for a total value of $41,892,853.20. Following the sale, the vice president now owns 26,877 shares in the company, valued at approximately $10,349,795.16. The disclosure for this sale can be found here. Insiders have sold 147,927 shares of company stock worth $57,064,459 in the last 90 days. Insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG traded down $8.28 during midday trading on Wednesday, reaching $380.37. The company’s stock had a trading volume of 1,107,969 shares, compared to its average volume of 1,601,620. The firm has a market capitalization of $134.92 billion, a price-to-earnings ratio of 68.66, a PEG ratio of 4.93 and a beta of 1.39. The firm has a 50 day moving average price of $385.34 and a two-hundred day moving average price of $351.97. Intuitive Surgical, Inc. has a fifty-two week low of $254.85 and a fifty-two week high of $403.76.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, topping analysts’ consensus estimates of $1.40 by $0.10. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The firm had revenue of $1.89 billion during the quarter, compared to analyst estimates of $1.87 billion. During the same period in the previous year, the company posted $1.00 EPS. The company’s revenue for the quarter was up 11.5% on a year-over-year basis. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.